Is IVF in Brazil regulated? ANVISA, CFM, and what SisEmbrio reports.

Brazil has two distinct layers of oversight: ANVISA’s technical and sanitary requirements for reproductive cells and embryos, and the Federal Council of Medicine’s ethical rules for assisted reproduction. These are more specific than a general promise of “high standards.”

Regulation does not replace individual clinical judgment, your clinic’s protocols, or careful interpretation of outcomes for patients like you. For how results are discussed on this site, see Understanding outcomes.

ANVISA’s framework (including RDC 771/2022 as described on our Why Brazil page) addresses quality, safety and traceability for centers handling germ cells, germinal tissues and human embryos.

In the standards table published on Why Brazil, ANVISA · RDC 771/2022 is summarized as: technical and sanitary requirements for centers handling germ cells, germinal tissues and human embryos, including quality, safety and traceability.

Laboratory care at treating clinics includes identity checks, documented handling, equipment monitoring, controlled storage and communication with the medical team within that sanitary framework. Brazil Fertility coordinates the international program; it is not a treating clinic and does not claim separate laboratory accreditation beyond disclosing the clinics that provide care.

The ANVISA legis thematic link already published on this site is the entry point we use for the germ-cell and embryo sanitary norms. We do not invent additional article numbers beyond the RDC 771/2022 framing already approved on Why Brazil.

CFM Resolution 2,320/2022 sets medical ethics, informed consent, donor-related rules and limits on embryo transfer. It is the ethical (deontological) device Brazilian physicians follow for assisted reproduction, published in the Official Gazette (DOU) on 20 September 2022 and replacing Resolution 2,294/2021.

CFM’s own September 2022 summary notes that the resolution updates ethical criteria for assisted reproduction in Brazil—including embryo-generation and transfer framing, donation rules, and alignment topics discussed publicly by the Council—while the PDF remains the primary text for claims.

From the resolution text itself (paraphrased at high level—not a substitute for reading the PDF or discussing your case with a physician): free and informed consent is mandatory for everyone undergoing assisted-reproduction techniques; medical aspects, biological, legal and ethical information, and unit results with the proposed technique should be explained in a specific consent form completed after discussion between the parties.

The resolution also sets upper limits on how many embryos may be transferred according to the recipient’s age (and uses donor age at collection when donor oocytes are involved), with a separate rule for euploid embryos after genetic diagnosis. It addresses non-commercial gamete and embryo donation, confidentiality rules with limited kinship exceptions, and clinic responsibilities such as medical leadership registration and permanent records of pregnancies and outcomes.

We paraphrase only at this level. Do not treat this page as legal advice, a full translation, or a claim that any particular accreditation logo applies to Brazil Fertility. For donor pathways and transfer decisions, your treating physician explains how the rules apply to your plan.

SisEmbrio (Sistema Nacional de Produção de Embriões) is ANVISA’s national system related to embryo production / assisted-reproduction activity reporting. On Why Brazil and elsewhere on this site we state clearly: activity figures are not patient-specific live-birth rates.

National production or activity dashboards answer a different question from clinic-specific live-birth rates by age, egg source or transfer type. They should not be quoted as marketing success rates for an individual patient or as a substitute for Understanding outcomes.

When you evaluate any figure—national or clinic-level—ask what is being counted, which patients are included, and whether the endpoint is pregnancy, live birth, or laboratory activity.

When this page was prepared (30 September 2026), the official SisEmbrio landing page on gov.br/anvisa identified the system as Sistema Nacional de Produção de Embriões. Use that page for current dashboards; do not equate its activity framing with individualized live-birth marketing.

Federal sanitary and ethical frameworks set baseline expectations. They do not choose your protocol, guarantee a pregnancy, or turn a national activity report into a personal prognosis.

Your medical care sits with the identified clinic and physician. Laboratory work—fertilization, culture, genetic assessment when indicated, and cryopreservation—happens under that clinic’s protocols and Brazil’s sanitary framework for reproductive cells and embryos.

A clinic’s historical result is not a prediction for one person. Your physician can discuss the evidence relevant to your circumstances.

International comparison pages on this site (IVF Brazil vs the USA) describe U.S. professional and reporting context separately. Neither country’s framework replaces a personal clinical plan.

Inside the laboratory, embryology teams handle fertilization (including ICSI when appropriate), culture, assessment and cryopreservation. Availability of a technology does not mean it is suitable or necessary in every cycle.

This site describes laboratory systems and pathways used at ENNE and Nilo Frantz Medicina Reprodutiva without inventing accreditation claims for Brazil Fertility as an organization. Ask your treating team which systems and checks apply to your cycle.

Useful questions include: Who is the treating physician and medical director? How does the center handle identity checks, traceability and informed consent? How are donor pathways explained under CFM rules? What outcomes are reported—and with which denominators?

Ask how SisEmbrio or other national reporting relates (or does not relate) to the figures you are shown. Ask for written consent materials and time to review them before procedures.

• Treating clinic identity and physician responsible for your care.
• Consent process and what results the unit discusses for the proposed technique.
• How embryo-transfer limits and donor rules are explained for your pathway.
• Whether quoted figures are activity counts, pregnancies or live births—and for which patients.
• How records and infectious-disease controls are maintained for inspection.

Brazil Fertility is the English-speaking international patient program—not a treating clinic. Medical treatment takes place at ENNE in São Paulo or Nilo Frantz Medicina Reprodutiva in Porto Alegre (Grupo Nilo Frantz). The treating clinic and physician are identified in your individual care plan.

When you are ready, use the contact page to ask about regulation, clinics or planning care. A simple first conversation; no appointment fee or payment is required to begin.

For the international-patient hub and cost orientation, continue with IVF in Brazil and Why Brazil. For laboratory detail and outcome interpretation, use Medicine & science and Understanding outcomes.